Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2023 Feb 27;23:190. doi: 10.1186/s12885-023-10666-z

Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

Feng Ling 1,#, Shengen Xu 2,#, Xiaochen Li 1, Xingwang Sun 1, Wenbo Long 1,
PMCID: PMC9969661  PMID: 36849899

Correction: BMC Cancer 23, 169 (2023)

https://doi.org/10.1186/s12885-023-10629-4

Following publication of the original article [1], the authors identified an error in the author name of Feng Ling. The given name and family name were erroneously transposed.

The incorrect author name is: Ling Feng

The correct author name is: Feng Ling

The author group has been updated above and the original article [1] has been corrected.

Footnotes

Feng Ling and Shengen Xu contributed equally to this work.

Reference

  • 1.Ling F, Xu S, Li X, et al. Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy. BMC Cancer. 2023;23:169. doi: 10.1186/s12885-023-10629-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES